Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma.

Miguel, Antonio; Sendra, Luis; Noé, Verónica; Ciudad, Carles J; Dasí, Francisco; Hervas, David; Herrero, María José; Aliño, Salvador F.

Afiliação

Miguel A; Department of Pharmacology, Faculty of Medicine, University of Valencia.
Sendra L; Department of Pharmacology, Faculty of Medicine, University of Valencia.
Noé V; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Barcelona.
Ciudad CJ; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Barcelona.
Dasí F; Research University Hospital of Valencia, INCLIVA Health Research Institute; Department of Physiology, Faculty of Medicine, University of Valencia Foundation.
Hervas D; Biostatistics Unit.
Herrero MJ; Department of Pharmacology, Faculty of Medicine, University of Valencia; Pharmacogenetics Unit, Instituto de Investigación Sanitaria La Fe (IIS La Fe).
Aliño SF; Department of Pharmacology, Faculty of Medicine, University of Valencia; Clinical Pharmacology Unit, ACM Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Onco Targets Ther ; 10: 503-514, 2017.

Article em En | MEDLINE | ID: mdl-28176947